BMRN position history
The shares of Biomarin Pharmaceutical (BMRN) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 16,403 shares, $1.3M, 0.19% of portfolio
- 2021 Q4: 12,237 shares, $1.1M, 0.16% of portfolio, Reduce −25.4%
- 2022 Q1: 11,587 shares, $893K, 0.14% of portfolio, Reduce −5.3%
- 2022 Q2: 11,569 shares, $959K, 0.18% of portfolio, Reduce −0.2%
- 2022 Q3: 11,300 shares, $958K, 0.19% of portfolio, Reduce −2.3%
- 2022 Q4: 10,834 shares, $1.1M, 0.20% of portfolio, Reduce −4.1%
- 2023 Q1: 10,877 shares, $1.1M, 0.19% of portfolio, Add +0.4%
- 2023 Q2: 10,981 shares, $952K, 0.16% of portfolio, Add +1.0%
- 2023 Q3: 14,222 shares, $1.3M, 0.22% of portfolio, Add +29.5%
- 2023 Q4: 14,668 shares, $1.4M, 0.23% of portfolio, Add +3.1%
- 2024 Q1: 44,352 shares, $2.6M, 0.39% of portfolio, Add +202.4%
- 2024 Q2: 16,855 shares, $1.4M, 0.21% of portfolio, Reduce −62.0%
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 78,170 shares, $4.4M, 0.65% of portfolio, New
- 2026 Q2: 77,705 shares, $4.4M, 0.60% of portfolio, Reduce −0.6%
- 2026 Q3: 73,615 shares, $4.4M, 0.58% of portfolio, Reduce −5.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|